MedTrace Logo

Maternal and Perinatal Pregnancy Outcome in Women With Heterozygous Hemoglobinopathies

NCT03837119 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 540

Last updated 2024-12-12

No results posted yet for this study

Summary

This retrospective study aims to investigate pregnancy outcome in women with heterozygous hemoglobinopathies (regarding gestational diabetes, cholestasis and urinary tract infections) and to analyze if there are aggravated maternal and/or perinatal risks.

Conditions

  • Heterozygous Haemoglobinopathy

Interventions

OTHER

pregnancy outcome

descriptive statistics of variables

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Irene Hoesli, Prof. Dr. MD · Frauenklinik Universitätsspital Basel

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-04
Primary Completion
2021-04-11
Completion
2021-04-11

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03837119 on ClinicalTrials.gov